1,721,036 research outputs found

    Medication and symptom management in persons living with HIV. perceptions and collaboration of persons living with HIV, their close support persons and healthcare providers

    Get PDF
    Over the past two decades, developments in the treatment and monitoring of HIV Infection have radically reduced morbidity and mortality rates among those affected by it [1]. Between 1996 and 2005, the estimated life expectancy for persons living with HIV (PLWH) placed on combined antiretroviral therapy (cART) at age 20 rose from 36.1 to 49.4 years [2]. Focusing on the improvement of health outcomes for the estimated 33 million PLWH worldwide, the situation differs considerably between low- and high-resource settings. Broader access to cART should substantially improve health outcomes for PLWH in low-resource settings, where supplies currently meet only 31% of the estimated global need [3]. However, such steep improvements are no longer a realistic option for high-resource settings. In western and central Europe, for example, longterm treatment is already provided to 90 -100% of PLWH and initial drops in mortality and morbidity have been sustained [4]. In high resource settings, though, long-term treatment experiences have shown that non-adherence to medication regimens is a serious issue. Since ART demands a constant level of medication to suppress viral replication, once started it has to continue without interruption. Compelling evidence has linked treatment interruptions, including medically guided ones, with poorer clinical outcomes compared to continuous treatment, i.e., near-perfect adherence [5]. However, long term adherence is complicated by a range of barriers, including the medications’ adverse effects: estimates of prescribed cART doses actually taken in Europe and Northern America range from 60%-70% [5-8]. As a result, medications’ adverse effects, opportunistic infections and comorbidities keep the prevalence of symptoms consistently high, averaging 8-14 symptoms per person [9-12]; and a high number of distressing symptoms has been shown to further complicate adherence to cART [9]. Regarding the stabilization of health outcomes for this treatment-experienced population of PLWH, major advances are no longer possible based solely on treatment access. It is clearly necessary to formulate new management strategies that consider multiple aspects of this chronic condition, focusing in particular on the skills needed by PLWH and their close support persons (CSPs) to manage their condition at home on a daily basis. In order to improve health outcomes for patients with chronic conditions, various studies have shown a need for profound changes across diverse levels of the health care system [9, 13, 14]. The WHO publication ‘Innovative Care for Chronic Conditions’ structures chronic care management areas requiring change into micro, meso, and macro levels, with each level interacting with and dynamically influencing the others. The macro level consists of policy makers who influence standards and incentives for quality care; the meso level includes healthcare organizations and communities; and the micro level is the level of patient interaction, where patients’ self management and collaboration between health care providers and patients are key issues [15]. By providing a fuller understanding of PLWH’s self-management and collaboration with CSPs and health care providers (HCPs) within the care process, the research represented here should help answer questions of how and where to improve care for PLWH on the micro (patient) level. In the context of chronic disease management, “self-management” has become a widely used term, encompassing the day-to-day activities a chronic illness patient performs to minimize the consequences of his or her condition. Such actions vary based on the person’s perceptions, experiences and expertise, but share the focus of optimizing health outcomes, whether by retarding deterioration, maintaining a given level of health, or improving overall wellness [16-18]. Additionally selfmanagement is increasingly recognized as a dynamic process that includes active collaboration with others, especially close support persons (e.g., partners, friends, family) and healthcare providers [18, 19]. Yet the skills that enable healthcare providers and close support persons to work with PLWH’s self-management have only been vaguely described. Although patient self-management shows similarities across a range of chronic conditions, every condition has unique challenges that require specialized self-management tasks. HIV specific self-management tasks have been summarized into eight categories: medication management, symptom management, substance use management, lifestyle management, emotional management, role management, transmission management, and social management. From a medical perspective with a focus on improving health outcomes, medication and symptom management may be regarded as the core tasks of HIV self-management. After all, a person’s experience of symptoms is closely related to adherence to cART (i.e., adherence decisions are often based upon symptoms), and adherence is closely related to treatment success [9, 20, 21]. In the current literature, medication management and symptom management – the two selfmanagement tasks upon which this thesis focuses – have mainly been described in a fragmented way, with close attention paid only to one or the other, despite considerable evidence linking the two closely [9, 21-23]. Medication management encompasses decisions related to initiating or changing cART regimens [24- 26]. Once started, the new or changed regimens have to be integrated into daily life and adherence maintained over time. Eventually, this also entails the management of adherence related obstacles [6, 27]. Opportunistic diseases and/or co-morbidities often require further medication management. Symptom management encompasses the assessment, evaluation and monitoring of symptoms [21]. Decisions are necessary on how to deal with symptoms, such as when to contact healthcare providers, whether or not to alter exercise or diet, and when to take — or not take — certain medications [28]. For PLWH, the formulation and adoption of many medication and symptom management strategies involves collaboration with their HCPs and CSPs; yet, despite the seemingly obvious benefits of such collaboration, the related processes are only vaguely understood. Since self-management activities regarding both medications and symptoms are closely associated with health outcomes, a fuller understanding of such activities is necessary to improve related services. The overall aim of this exploratory mixed method research program was to describe PLWH’s symptom and medication management activities, focusing on collaboration between PLWH, CSPs and HCPs, from the perspectives of all three groups. Four articles presented the results. The first, a clinical case report, describes the complexity of self-management support in clinical care and illustrates how interventions that were individualized, culturally sensitive, and provided by a team of health care providers enabled the patient to optimize his adherence, which led to significant improvement in his clinical surrogate markers and subjective quality of life. Second, a literature review summarized the evidence resulting from randomised controlled trials of interventions designed to enhance medication adherence to antiretroviral therapy. The review showed that effective programs combine several methods, and highlighted a continuing need for long term programs tailored to patient needs. The third article dealt with PLWH’s experiences with the management of medications and symptoms, along with their collaborations with close support persons and health care providers within this process. The narratives of 13 PLWH revealed that even small changes in health and treatment could change participants’ impressions of maintaining or “losing their grip” on HIV. To keep their grip, participants constantly monitored their condition, developed expertise in care and symptom management, and included input from healthcare providers and close support persons in their management processes. Despite the clear need for partnerships with HCP, PLWH described this area of collaboration as sometimes supportive, sometimes a hindrance. The final article reported on the use of an exploratory mixed methods approach to examine the collaboration of PLWH and their CSP within the process of symptom management, including a comparison of the two players symptom reports. Qualitative results revealed that collaboration typically depended on distinct but integrative positions of PLWH and CSP, with the PLWH in a clear leadership role. These roles were reflected in diverse themes of daily symptom management, and later confirmed in the quantitatively assessed symptom experience reports, where PLWH reported significantly more symptoms over the previous week – an average of 16 (Q1=9; Q3=24), compared to CSPs’ 12 (Q1=5; Q3=17). This disproved two of our initial hypotheses – first, that certain symptoms would be reported more often by CSPs (this was never the case), and second, that where the PLWH reported symptoms as very distressing, symptom reports by PLWH and CSP would not differ. The results of this research program contributed to the existing knowledge by using the conceptualization of Loring and Holman to describe HIV specific self-management tasks and skills [17]. This comprehensive description can be used as a guiding framework to plan both clinical selfmanagement support interventions and HIV self-management oriented research projects. Another important contribution was the replication of the observation by Thorne et al. that chronically ill patients at some point made an active decision to control the effects of their condition [18]. The constitutive pattern “I have a grip on HIV - HIV has a grip on me” revealed a similar phenomenon. However, in contrast to earlier investigations, examining this phenomenon provided insights into a dynamic process. Throughout the course of the condition, health and/or treatment changes could influence the perception of “having a grip on HIV” or losing it. These alternating conditions could constitute a phenomenon more pregnant in HIV than in chronic conditions with more predictable illness trajectories. Additionally, since the “HIV has a grip on me” perception was associated with feelings of uncertainty, fear and loss of morale, and since depressive symptoms clearly hinder effective self-management, this phenomenon certainly warrants clinical examination [28-30]. A particularly important outcome of this research program is the deepening of our understanding of collaboration between PLWH and CSP. Concordant with earlier reports, the narratives of PLWH and CSP presented in Chapter Six revealed that PLWH collaborated closely with their CSPs to manage their condition [31-33]. Yet, in contrast to earlier investigations, this collaboration was characterized by distinct roles: as ‘managers’, the PLWH took a clear lead on the overall management of the condition, whereas, as ‘companions’, their CSPs tried to find and support aspects of self-management. The PLWH’s leadership role was, in fact, much clearer here than in previous studies, which emphasized the partnership aspects of the PLWH/CSP relationship. This insight into the collaboration of PLWH and CSP may provide a foundation upon which to integrate CSP into research based clinical interventions. To our knowledge, concordance between the symptom reports of patients and their CSPs has never before been described for the PLWH population. We therefore provide the first recorded insights into the issue. Compared to earlier investigations in cancer populations, where CSPs reported more symptoms than patients [34, 35], PLWH in this study consistently reported significantly more. Additionally, we described an inter-method inconsistency that indicates a need to better understand management of neurocognitive symptoms from PLWH’s and CSP’s perspectives. Our qualitative analysis revealed a cluster of neurocognitive symptoms that CSPs recognized but did not wish to discuss with their partners; and the quantitative assessment of concordance between symptom reports revealed that all symptoms were reported more often by the PLWH. Regarding collaborations with HCPs, in accord with previous research, our results illustrated that this group can both hinder and enable PLWH’s self-management [36-38]. PLWH’s narratives provided insights into the respective negative and positive aspects of their relationships with HCPs. On one hand, the need for providers to use a patient centered approach, including recognizing each person as a unique human being, is highlighted and has already proved important in a broad range of studies [36,38-40]. On the other hand, our findings also highlight the importance of HIV-specific competence on the part of healthcare providers. Second in importance to overall medical competence, this includes the ability to assess a patient’s symptom experience in a non-judgmental manner, to collaboratively develop medication and symptom management strategies, to provide ongoing education on those topics, and finally to assist patients in decision making and in the coordination of their various health problems. Also significantly, this research program determined that CSP were only very slightly integrated into clinical care, meaning their collaboration with health care providers was marginal. Since PLWH need their CSPs to act as active partners to manage the disease, not integrating them into self-management support is a missed opportunity to strengthen PLWH’s self-management. In summary, this study program provided new insights and raised further questions. Subsequent research should focus on a qualitative meta-synthesis and development of the phenomenon of “having a grip” or “being in control” of a chronic condition, descriptions of HCPs’ perspectives of collaboration, a better understanding of the concordance between PLWH’s symptom reports and those of CSP – particularly in relation to neurocognitive symptoms and regarding strategies for integrating CSP’s into intervention programs and clinical processes

    Going Beyond Counting First Authors in Author Co-citation Analysis

    Get PDF
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    Variations on the Author

    Get PDF
    “Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship

    Appropriate Similarity Measures for Author Cocitation Analysis

    Get PDF
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Dispelling the Myths Behind First-author Citation Counts

    Get PDF
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Author Index

    No full text
    Nao informado

    koamabayili/VECTRON-author-checklist: VECTRON author checklist

    No full text
    We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
    corecore